Related Experiment Video
Updated: Nov 29, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
The multifaceted role of TRAIL signaling in cancer and immunity
Ludmila Cardoso Alves1, Nadia Corazza1, Olivier Micheau2
1Institute of Pathology, University of Bern, Switzerland.
Abstract:
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily that can lead to the induction of apoptosis in tumor or infected cells. However, activation of TRAIL signaling may also trigger nonapoptotic pathways in cancer and in nontransformed cells, that is, immune cells. Here, we review the current knowledge on noncanonical TRAIL signaling. The biological outcomes of TRAIL signaling in immune and malignant cells are presented and explained, with a focus on the role of TRAIL for natural killer (NK) cell function. Furthermore, we highlight the technical difficulties in dissecting the precise molecular mechanisms involved in the switch between apoptotic and nonapoptotic TRAIL signaling. Finally, we discuss the consequences thereof for a therapeutic manipulation of TRAIL in cancer and possible approaches to bypass these difficulties.
Insights
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) can induce apoptosis but also nonapoptotic pathways in cancer and immune cells. This review explores TRAIL
Area of Science:
- Immunology
- Molecular Biology
- Cancer Biology
Background:
- TRAIL (TNF-related apoptosis-inducing ligand) is a TNF superfamily member.
- TRAIL signaling induces apoptosis in tumor and infected cells.
- TRAIL can also activate nonapoptotic pathways in cancer and immune cells.
Purpose of the Study:
- To review current knowledge on noncanonical TRAIL signaling.
- To explain biological outcomes of TRAIL signaling in immune and malignant cells.
- To focus on TRAIL's role in natural killer (NK) cell function.
Main Methods:
- Literature review of TRAIL signaling.
- Analysis of molecular mechanisms.
- Discussion of therapeutic implications.
Main Results:
- TRAIL signaling has diverse biological outcomes beyond apoptosis.
- NK cell function is significantly influenced by TRAIL.
- Dissecting TRAIL's apoptotic vs. nonapoptotic switch presents technical challenges.
Conclusions:
- Understanding noncanonical TRAIL signaling is crucial for cancer therapy.
- Challenges exist in manipulating TRAIL therapeutically.
- New approaches are needed to bypass difficulties in TRAIL pathway manipulation.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Immunotherapy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...

